CHICAGO (EGMN) - Vaginal brachytherapy is just as effective as pelvic external beam radiotherapy for treating high-intermediate risk endometrial cancer, but with fewer side effects, according to the results of a randomized trial in more than 400 patients.Results from the PORTEC-2 (Postoperative Radiation Therapy in Endometrial Carcinoma-2) trial indicate that the 3-year survival rates for the two treatment methods are statistically equivalent, as are the 3-year rates of vaginal relapse. But the multicenter,...